JPH03504982A - 内毒素血症の治療のためのインタロイキン―２の使用 - Google Patents

内毒素血症の治療のためのインタロイキン―２の使用

Info

Publication number
JPH03504982A
JPH03504982A JP2504890A JP50489090A JPH03504982A JP H03504982 A JPH03504982 A JP H03504982A JP 2504890 A JP2504890 A JP 2504890A JP 50489090 A JP50489090 A JP 50489090A JP H03504982 A JPH03504982 A JP H03504982A
Authority
JP
Japan
Prior art keywords
endotoxin
administration
interleukin
plasma
endotoxins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2504890A
Other languages
English (en)
Japanese (ja)
Inventor
ニーチェ　ディートリッヒ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JPH03504982A publication Critical patent/JPH03504982A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2504890A 1989-03-28 1990-03-28 内毒素血症の治療のためのインタロイキン―２の使用 Pending JPH03504982A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3910011A DE3910011A1 (de) 1989-03-28 1989-03-28 Verwendung von interleukin-2 bei ausgedehnten bakteriellen infektionen
DE3910011.1 1989-03-28

Publications (1)

Publication Number Publication Date
JPH03504982A true JPH03504982A (ja) 1991-10-31

Family

ID=6377301

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2504890A Pending JPH03504982A (ja) 1989-03-28 1990-03-28 内毒素血症の治療のためのインタロイキン―２の使用

Country Status (5)

Country Link
EP (1) EP0428636B1 (enExample)
JP (1) JPH03504982A (enExample)
AT (1) ATE120092T1 (enExample)
DE (2) DE3910011A1 (enExample)
WO (1) WO1990011083A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1044781C (zh) * 1994-02-05 1999-08-25 丹东市生物制品免疫技术应用研究中心 复方免疫抗生素
RU2421160C1 (ru) * 2009-12-24 2011-06-20 Государственное образовательное учреждение дополнительного профессионального образования "Новокузнецкий государственный институт усовершенствования врачей Федерального агентства по здравоохранению и социальному развитию" Способ лечения гнойных ран мягких тканей

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8600042L (sv) * 1986-01-07 1987-07-08 Mediplast Ab Anordning for reglering av en slangs genomstromningsarea
US4879111A (en) * 1986-04-17 1989-11-07 Cetus Corporation Treatment of infections with lymphokines

Also Published As

Publication number Publication date
EP0428636B1 (de) 1995-03-22
WO1990011083A1 (de) 1990-10-04
ATE120092T1 (de) 1995-04-15
EP0428636A1 (de) 1991-05-29
DE59008759D1 (de) 1995-04-27
DE3910011A1 (de) 1990-10-04
DE3910011C2 (enExample) 1992-09-10

Similar Documents

Publication Publication Date Title
Nanji et al. Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease)
JP3835811B2 (ja) ホスファターゼ又はその誘導体を含む製薬学的組成物
Galanos et al. Biological activities of lipid A complexed with bovine‐serum albumin
Engelhardt et al. Phase I trial of intravenously administered endotoxin (Salmonella abortus equi) in cancer patients
Donaruma Synthetic biologically active polymers
Chen et al. Postoperative infection and survival in osteosarcoma patients: Reconsideration of immunotherapy for osteosarcoma
JP2021520373A (ja) Ｃｇｒｐを阻害する際に使用するための神経毒素
IL259228B2 (en) Control of cellular redox levels
JP2001519471A (ja) アンジェリカ・ギガス・ナカイから精製した新規のペクチン質多糖類とその精製方法およびその免疫刺激剤としての使用
EP0347501A1 (en) Modulation of lymphokine-resistant cellular states by dsRNAs
US5240909A (en) Use of lactoferrin for treatment of toxic effects of endotoxins
van der Meer The effects of recombinant interleukin-1 and recombinant tumor necrosis factor on non-specific resistance to infection
CN114099540A (zh) 阳离聚合物在制备用于清除肠道微生物毒素以及治疗肿瘤药物的应用
JPH0427964B2 (enExample)
KR20110119677A (ko) 염증성장질환 및 1형 당뇨병치료를 위한 ａｐｌ 펩티드의 사용
JPS6366128A (ja) 動物およびヒト癌の治療に用いられるｃ反応性タンパク質
EP0632726A4 (en) METHOD FOR TREATING THE CAPOSISAR COME AND FOR AVOIDING OR REDUCING VASILITY.
Haranaka et al. Role of lipid A in the production of tumor necrosis factor and differences in antitumor activity between tumor necrosis factor and lipopolysaccharide
Kleef et al. Fever, pyrogens and cancer
Auclair et al. Prolonged endotoxemia enhances the renal injuries induced by gentamicin in rats
Mattar et al. Local infusion of FGF-saporin reduces intimal hyperplasia
US4711876A (en) Process for the treatment and remission of AIDS (acquired immune deficiency syndrome)
DE3910011C2 (enExample)
JPH09227392A (ja) 抗腫瘍剤及びその製造法
JP2583183B2 (ja) 生理活性を有するグリコーゲンの製法及び生理活性